A citation-based method for searching scientific literature

Geffen Kleinstern, Nicola J Camp, Lynn R Goldin, Celine M Vachon, Claire M Vajdic, Silvia de Sanjose, J Brice Weinberg, Yolanda Benavente, Delphine Casabonne, Mark Liebow, Alexandra Nieters, Henrik Hjalgrim, Mads Melbye, Bengt Glimelius, Hans-Olov Adami, Paolo Boffetta, Paul Brennan, Marc Maynadie, James McKay, Pier Luigi Cocco, Tait D Shanafelt, Timothy G Call, Aaron D Norman, Curtis Hanson, Dennis Robinson, Kari G Chaffee, Angela R Brooks-Wilson, Alain Monnereau, Jacqueline Clavel, Martha Glenn, Karen Curtin, Lucia Conde, Paige M Bracci, Lindsay M Morton, Wendy Cozen, Richard K Severson, Stephen J Chanock, John J Spinelli, James B Johnston, Nathaniel Rothman, Christine F Skibola, Jose F Leis, Neil E Kay, Karin E Smedby, Sonja I Berndt, James R Cerhan, Neil Caporaso, Susan L Slager. Blood 2018
Times Cited: 18







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.
Philip J Law, Sonja I Berndt, Helen E Speedy, Nicola J Camp, Georgina P Sava, Christine F Skibola, Amy Holroyd, Vijai Joseph, Nicola J Sunter, Alexandra Nieters,[...]. Nat Commun 2017
47
38

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.
Maria Chiara Di Bernardo, Dalemari Crowther-Swanepoel, Peter Broderick, Emily Webb, Gabrielle Sellick, Ruth Wild, Kate Sullivan, Jayaram Vijayakrishnan, Yufei Wang, Alan M Pittman,[...]. Nat Genet 2008
270
27

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
Helen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, Martin J S Dyer, Amy Holroyd, Yufei Wang, Nicola J Sunter, Larry Mansouri, Gunnar Juliusson, Karin E Smedby,[...]. Nat Genet 2014
129
27

The Mayo Clinic Biobank: a building block for individualized medicine.
Janet E Olson, Euijung Ryu, Kiley J Johnson, Barbara A Koenig, Karen J Maschke, Jody A Morrisette, Mark Liebow, Paul Y Takahashi, Zachary S Fredericksen, Ruchi G Sharma,[...]. Mayo Clin Proc 2013
146
22

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Michael Hallek, Bruce D Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillaume Dighiero, Hartmut Döhner, Peter Hillmen, Michael J Keating, Emili Montserrat, Kanti R Rai,[...]. Blood 2008
22


Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.
Lynn R Goldin, Mark C Lanasa, Susan L Slager, James R Cerhan, Celine M Vachon, Sara S Strom, Nicola J Camp, Logan G Spector, Jose F Leis, Vicki A Morrison,[...]. Br J Haematol 2010
53
22

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.
Sonja I Berndt, Nicola J Camp, Christine F Skibola, Joseph Vijai, Zhaoming Wang, Jian Gu, Alexandra Nieters, Rachel S Kelly, Karin E Smedby, Alain Monnereau,[...]. Nat Commun 2016
66
22

Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.
Leah H Schinasi, Elizabeth E Brown, Nicola J Camp, Sophia S Wang, Jonathan N Hofmann, Brian C Chiu, Lucia Miligi, Laura E Beane Freeman, Silvia de Sanjose, Leslie Bernstein,[...]. Br J Haematol 2016
25
16

B-cell clones as early markers for chronic lymphocytic leukemia.
Ola Landgren, Maher Albitar, Wanlong Ma, Fatima Abbasi, Richard B Hayes, Paolo Ghia, Gerald E Marti, Neil E Caporaso. N Engl J Med 2009
243
16

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Hong Fang, Kaaren K Reichard, Kari G Rabe, Curtis A Hanson, Timothy G Call, Wei Ding, Saad S Kenderian, Eli Muchtar, Susan M Schwager, Jose F Leis,[...]. Am J Hematol 2019
14
21

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.
J L Binet, A Auquier, G Dighiero, C Chastang, H Piguet, J Goasguen, G Vaugier, G Potron, P Colona, F Oberling,[...]. Cancer 1981
16

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Julio Delgado, Michael Doubek, Tycho Baumann, Jana Kotaskova, Stefano Molica, Pablo Mozas, Alfredo Rivas-Delgado, Fortunato Morabito, Sarka Pospisilova, Emili Montserrat. Am J Hematol 2017
57
16

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.
Massimo Gentile, Tait D Shanafelt, Davide Rossi, Luca Laurenti, Francesca R Mauro, Stefano Molica, Giovanna Cutrona, Giuseppina Uccello, Melissa Campanelli, Ernesto Vigna,[...]. Blood 2016
39
16

The CLL-IPI applied in a population-based cohort.
Caspar da Cunha-Bang, Ilse Christiansen, Carsten Utoft Niemann. Blood 2016
40
16

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.
Dalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, Sara E Dobbins, María Torres, Mahmoud Mansouri, Clara Ruiz-Ponte, Anna Enjuanes, Richard Rosenquist, Angel Carracedo,[...]. Nat Genet 2010
174
16

Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
Andy C Rawstron, Tait Shanafelt, Mark C Lanasa, Ola Landgren, Curtis Hanson, Alberto Orfao, Peter Hillmen, Paolo Ghia. Cytometry B Clin Cytom 2010
69
16

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Michael Hallek, Bruce D Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillermo Dighiero, Hartmut Döhner, Peter Hillmen, Michael Keating, Emili Montserrat, Nicholas Chiorazzi,[...]. Blood 2018
625
16

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio,[...]. J Clin Oncol 2017
102
11

Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.
Beatrice S Melin, Jill S Barnholtz-Sloan, Margaret R Wrensch, Christoffer Johansen, Dora Il'yasova, Ben Kinnersley, Quinn T Ostrom, Karim Labreche, Yanwen Chen, Georgina Armstrong,[...]. Nat Genet 2017
155
11

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial.
Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart,[...]. Blood 2017
47
11

Most common 'sporadic' cancers have a significant germline genetic component.
Yi Lu, Weronica E Ek, David Whiteman, Thomas L Vaughan, Amanda B Spurdle, Douglas F Easton, Paul D Pharoah, Deborah J Thompson, Alison M Dunning, Nicholas K Hayward,[...]. Hum Mol Genet 2014
61
11

Prevalence of monoclonal gammopathy of undetermined significance.
Robert A Kyle, Terry M Therneau, S Vincent Rajkumar, Dirk R Larson, Matthew F Plevak, Janice R Offord, Angela Dispenzieri, Jerry A Katzmann, L Joseph Melton. N Engl J Med 2006
807
11

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.
Molly Went, Amit Sud, Asta Försti, Britt-Marie Halvarsson, Niels Weinhold, Scott Kimber, Mark van Duin, Gudmar Thorleifsson, Amy Holroyd, David C Johnson,[...]. Nat Commun 2018
61
11

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.
Ola Landgren, Sigurdur Y Kristinsson, Lynn R Goldin, Neil E Caporaso, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Magnus Bjorkholm, Ingemar Turesson. Blood 2009
108
11

Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
Alyssa I Clay-Gilmour, Shaji Kumar, S Vincent Rajkumar, Abdul Rishi, Robert A Kyle, Jerry A Katzmann, David L Murray, Aaron D Norman, Alexandra J Greenberg, Dirk R Larson,[...]. Leukemia 2019
5
40

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
Niels Weinhold, David C Johnson, Andrew C Rawstron, Asta Försti, Chi Doughty, Jayaram Vijayakrishnan, Peter Broderick, Nasrin B Dahir, Dil B Begum, Fay J Hosking,[...]. Blood 2014
27
11

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
Ola Landgren, Martha S Linet, Mary L McMaster, Gloria Gridley, Kari Hemminki, Lynn R Goldin. Int J Cancer 2006
103
11

Genome-wide association studies of cancer: current insights and future perspectives.
Amit Sud, Ben Kinnersley, Richard S Houlston. Nat Rev Cancer 2017
167
11

Familial risk of cancer: data for clinical counseling and cancer genetics.
Kari Hemminki, Xinjun Li, Kamila Czene. Int J Cancer 2004
83
11

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
11

Chronic lymphocytic leukemia.
Nicholas Chiorazzi, Kanti R Rai, Manlio Ferrarini. N Engl J Med 2005
11

Assessing the performance of prediction models: a framework for traditional and novel measures.
Ewout W Steyerberg, Andrew J Vickers, Nancy R Cook, Thomas Gerds, Mithat Gonen, Nancy Obuchowski, Michael J Pencina, Michael W Kattan. Epidemiology 2010
11

Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults.
Delphine Casabonne, Julia Almeida, Wendy G Nieto, Alfonso Romero, Paulino Fernández-Navarro, Arancha Rodriguez-Caballero, Santiago Muñoz-Criado, Marcos González Díaz, Yolanda Benavente, Silvia de Sanjosé,[...]. PLoS One 2012
28
11

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.
J Moreira, K G Rabe, J R Cerhan, N E Kay, J W Wilson, T G Call, J F Leis, D F Jelinek, S M Schwager, D A Bowen,[...]. Leukemia 2013
81
11

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.
M Gentile, T D Shanafelt, G Cutrona, S Molica, G Tripepi, I Alvarez, F R Mauro, N Di Renzo, F Di Raimondo, I Vincelli,[...]. Leukemia 2016
22
11

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
Pietro Bulian, Tait D Shanafelt, Chris Fegan, Antonella Zucchetto, Lilla Cro, Holger Nückel, Luca Baldini, Antonina V Kurtova, Alessandra Ferrajoli, Jan A Burger,[...]. J Clin Oncol 2014
115
11

A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL.
Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle-Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J M van Dongen,[...]. Blood 2018
46
11

Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.
William G Wierda, Susan O'Brien, Xuemei Wang, Stefan Faderl, Alessandra Ferrajoli, Kim-Anh Do, Jorge Cortes, Deborah Thomas, Guillermo Garcia-Manero, Charles Koller,[...]. Blood 2007
255
11

Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.
William G Wierda, Susan O'Brien, Xuemei Wang, Stefan Faderl, Alessandra Ferrajoli, Kim-Anh Do, Guillermo Garcia-Manero, Jorge Cortes, Deborah Thomas, Charles A Koller,[...]. J Clin Oncol 2011
95
11

Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, K Döhner, M Bentz, P Lichter. N Engl J Med 2000
11

Clinical staging of chronic lymphocytic leukemia.
K R Rai, A Sawitsky, E P Cronkite, A D Chanana, R N Levy, B S Pasternack. Blood 1975
11

Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, Thorsten Zenz, Marianna Rossi, Konstanze Döhner, Andreas Bühler, Sebastian Böttcher, Matthias Ritgen, Michael Kneba,[...]. Blood 2014
357
11

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.
Jayaram Vijayakrishnan, James Studd, Peter Broderick, Ben Kinnersley, Amy Holroyd, Philip J Law, Rajiv Kumar, James M Allan, Christine J Harrison, Anthony V Moorman,[...]. Nat Commun 2018
39
11

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy.
A C Rawstron, B Kennedy, P A Evans, F E Davies, S J Richards, A P Haynes, N H Russell, G Hale, G J Morgan, A S Jack,[...]. Blood 2001
191
11

Inherited genetic susceptibility to monoclonal B-cell lymphocytosis.
Dalemari Crowther-Swanepoel, Tanguy Corre, Amy Lloyd, Gianluca Gaidano, Bianca Olver, Fiona L Bennett, Chi Doughty, Daniela Toniolo, Federico Caligaris-Cappio, Paolo Ghia,[...]. Blood 2010
36
11

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.
Andy C Rawstron, Martin R Yuille, Julie Fuller, Matthew Cullen, Ben Kennedy, Stephen J Richards, Andrew S Jack, Estella Matutes, Daniel Catovsky, Peter Hillmen,[...]. Blood 2002
161
11

Prognostic factors and risk stratification in chronic lymphocytic leukemia.
Sameer A Parikh, Tait D Shanafelt. Semin Oncol 2016
43
11

Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.
T D Shanafelt, P Ghia, M C Lanasa, O Landgren, A C Rawstron. Leukemia 2010
156
11

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
S Barrio, T D Shanafelt, J Ojha, K G Chaffee, C Secreto, K M Kortüm, S Pathangey, D L Van-Dyke, S L Slager, R Fonseca,[...]. Leukemia 2017
34
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.